Table 2. Patient Characteristics (Continuous Variables).
| Full study cohort (n = 2,510) | Primary analysis (n = 923) | ART failure (n = 196) | No ART failure (n = 727) | |||||||||
| n | mean | sd | n | mean | sd | n | mean | sd | n | Mean | sd | |
| Age at ART starta | 2510 | 38.4 | 11.4 | 923 | 38.7 | 10.9 | 196 | 37.3 | 11.3 | 727 | 39.0 | 10.8 |
| Baseline CD41 | 2120 | 208.0 | 182.9 | 923 | 207.8 | 183.1 | 196 | 267.1 | 266.7 | 727 | 191.8 | 149.2 |
| Baseline BMI | 1911 | 20.7 | 3.2 | 727 | 20.8 | 3.1 | 150 | 20.9 | 3.0 | 577 | 20.8 | 3.1 |
| # days enrolled before ART start | 2510 | 292.3 | 468.7 | 923 | 299.9 | 437.7 | 196 | 247.8 | 373.4 | 727 | 314.0 | 452.7 |
a
p<.05 by Student t-test for difference in means between ART failures and non-failures, among patients included in the primary analysis.
1
p<0.001 by Wilcoxon rank sum test (non-parametric test) for equality of distributions between ART failures and non-failures, among patients included in the primary analysis.